Top

Published in:

01-12-2014

Identification and characterization of metastasis-associated gene/protein 1 (MTA1)

Authors: Yasushi Toh, Garth L. Nicolson

Published in: Cancer and Metastasis Reviews | Issue 4/2014

Abstract

Metastasis is a complex series of sequential events involving several gene products and the regulated expression of several tumor cell genes. Using rat mammary adenocarcinoma cell lines of differing metastatic potentials and a differential complementary DNA (cDNA) hybridization method, our laboratory embarked in 1992 on a project to identify candidate metastasis-associated genes. Among the genes that were found to be abundantly overexpressed in highly metastatic rat cell lines compared to poorly metastatic cell lines, we identified a completely novel gene without any homologous or related genes in the database in 1994. The full-length cDNA of this gene was cloned, sequenced, and named mta1 (metastasis-associated gene 1), and eventually, its human cDNA counterpart, MTA1, was also cloned and sequenced by our group. MTA1 has now been identified as one of the members of a gene family (MTA gene family). The products of the MTA genes, the MTA proteins, are transcriptional co-regulators that function in histone deacetylation and nucleosome remodeling. In this review, we will briefly discuss the researches for the identification and characterization of the mta1 gene, its human counterpart MTA1, and their protein products.

Liotta, L. A. (1986). Tumor invasion and metastases—role of the extracellular matrix: Rhoads memorial award lecture. Cancer Research, 46(1), 1–7.PubMed

Nicolson, G. L. (1988). Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites. Biochimica et Biophysica Acta, 948(2), 175–224.PubMed

Chambers, A. F., & Tuck, A. B. (1993). Ras-responsive genes and tumor metastasis. Critical Review of Oncogenesis, 4(2), 95–114.

Toh, Y., Pencil, S. D., & Nicolson, G. L. (1994). A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. Journal of Biological Chemistry, 269(37), 22958–22963.PubMed

Nawa, A., Nishimori, K., Lin, P., Maki, Y., Moue, K., Sawada, H., et al. (2000). Tumor metastasis-associated human MTA1 gene: its deduced protein sequence, localization, and association with breast cancer cell proliferation using antisense phosphorothioate oligonucleotides. Journal of Cell Biochemistry, 79(2), 202–212.CrossRef

Toh, Y., Oki, E., Oda, S., Tokunaga, E., Ohno, S., Maehara, Y., et al. (1997). Overexpression of the MTA1 gene in gastrointestinal carcinomas: correlation with invasion and metastasis. International Journal of Cancer, 74(4), 459–463.CrossRef

Toh, Y., Kuwano, H., Mori, M., Nicolson, G. L., & Sugimachi, K. (1999). Overexpression of metastasis-associated MTA1 mRNA in invasive oesophageal carcinomas. British Journal of Cancer, 79(11–12), 1723–1726.PubMedCentralPubMedCrossRef

Neri, A., Welch, D., Kawaguchi, T., & Nicolson, G. L. (1982). Development and biologic properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma. Journal of National Cancer Institute, 68(3), 507–517.

Nicolson, G. L., Gallick, G. E., Spohn, W. H., Lembo, T. M., & Tainsky, M. A. (1992). Transfection of activated c-H-rasEJ/psv2neo or psv2neo genes into rat mammary cells: rapid stimulation of clonal diversification of spontaneous metastatic and cell-surface properties. Oncogene, 7(6), 1127–1135.PubMed

10.

Pencil, S. D., Toh, Y., & Nicolson, G. L. (1993). Candidate metastasis-associated genes of the rat 13762NF mammary adenocarcinoma. Breast Cancer Research and Treatment, 25(2), 165–174.PubMedCrossRef

11.

Taniguchi, S., Miyamoto, S., Sadano, H., & Kobayashi, H. (1991). Rat elongation factor 1 alpha: sequence of cDNA from a highly metastatic fos-transferred cell line. Nucleic Acids Research, 19(24), 6949.PubMedCentralPubMedCrossRef

12.

Thompson, E. W., Brunner, N., Torri, J., Johnson, M. D., Boulay, V., Wright, A., et al. (1993). The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells. Clinical and Experimental Metastasis, 11(1), 15–26.PubMedCrossRef

13.

Brunner, N., Frandsen, T. L., Holst-Hansen, C., Bei, M., Thompson, E. W., Wakeling, A. E., et al. (1993). MCF7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780. Cancer Research, 53(14), 3229–3232.PubMed

14.

Zhang, R. D., Fidler, I. J., & Price, J. E. (1991). Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis. Invasion and Metastasis, 11(4), 204–215.PubMed

15.

Toh, Y., Pencil, S. D., & Nicolson, G. L. (1995). Analysis of the complete sequence of the novel metastasis-associated candidate gene, mta1, differentially expressed in mammary adenocarcinoma and breast cancer cell lines. Gene, 159(1), 97–104.PubMedCrossRef

16.

Manavathi, B., Singh, K., & Kumar, R. (2007). MTA family of coregulators in nuclear receptor biology and pathology. Nuclear Receptor Signaling, 5, 1–8.CrossRef

17.

Toh, Y., & Nicolson, G. L. (2009). The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications. Clinical and Experimental Metastasis, 26(3), 215–227.PubMedCrossRef

18.

Toh, Y., & Nicolson, G. L. (2011). MTA1 of the MTA (metastasis-associated) gene family and its encoded proteins: molecular and regulatory functions and its role in human cancer progression. Atlas of Genetics and Cytogenetics in Oncology and Haematology, 15(3), 303–315.

19.

Toh, Y., & Nicolson, G. L. (2013). Signaling pathways of MTA family proteins as regulators of cancer progression and metastasis. In R. R. Resende & H. Ulrich (Eds.), Trends in stem cell proliferation and cancer research (pp. 251–275). Dordrecht: Springer.CrossRef

20.

Singh, R. R., & Kumar, R. (2007). MTA family of transcriptional metaregulators in mammary gland morphogenesis and breast cancer. Journal of Mammary Gland Biology and Neoplasia, 12(2–3), 115–125.PubMedCrossRef

21.

Millard, C. J., Watson, P. J., Celardo, I., Gordiyenko, Y., Cowley, S. M., Robinson, C. V., et al. (2013). Class I HDACs share a common mechanism of regulation by inositol phosphates. Molecular Cell, 51(1), 57–67.PubMedCentralPubMedCrossRef

22.

Alqarni, S. S., Murthy, A., Zhang, W., Przewloka, M. R., Silva, A. P., Watson, A. A., et al. (2014). Insight into the architecture of the NuRD complex: structure of the RbAp48-MTA1 subcomplex. Journal of Biological Chemistry, 289(32), 21844–21855.PubMedCentralPubMedCrossRef

23.

Bowen, N. J., Fujita, N., Kajita, M., & Wade, P. A. (2004). Mi-2/NuRD: multiple complexes for many purposes. Biochimica et Biophysica Acta, 1677(1–3), 52–57.PubMedCrossRef

24.

Tong, J. K., Hassig, C. A., Schnitzler, G. R., Kingston, R. E., & Schreiber, S. L. (1998). Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. Nature, 395(6705), 917–921.PubMedCrossRef

25.

Xue, Y., Wong, J., Moreno, G. T., Young, M. K., Cote, J., & Wang, W. (1998). NuRD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Molecular Cell, 2(6), 851–861.PubMedCrossRef

26.

Zhang, Y., Ng, H. H., Erdjument-Bromage, H., Tempst, P., Bird, A., & Reinberg, D. (1999). Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes and Development, 13(15), 1924–1935.PubMedCentralPubMedCrossRef

27.

Wade, P. A., Gegonne, A., Jones, P. L., Ballesta, R. E., Aubry, F., & Wolffe, A. P. (1999). Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation. Nature Genetics, 23(1), 62–66.PubMedCrossRef

28.

Mazumdar, A., Wang, R. A., Mishra, S. K., Adam, L., Bagheri-Yarmand, R., Mandal, M., et al. (2001). Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nature Cell Biology, 3(1), 30–37.PubMedCrossRef

Title: Identification and characterization of metastasis-associated gene/protein 1 (MTA1)
Authors: Yasushi Toh
Garth L. Nicolson
Publication date: 01-12-2014
Publisher: Springer US
Published in: Cancer and Metastasis Reviews / Issue 4/2014
Print ISSN: 0167-7659
Electronic ISSN: 1573-7233
DOI: https://doi.org/10.1007/s10555-014-9510-8

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2014

Sugars in the microenvironment: the sticky problem of HA turnover in tumors

Preface

Molecular functions and significance of the MTA family in hormone-independent cancer

E-cadherin germline mutation carriers: clinical management and genetic implications

Microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapy

Role of MTA1 in head and neck cancers

Keynote webinar | Spotlight on antibody–drug conjugates in cancer